{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:00Z","timestamp":1792787880709,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T00:00:00Z","timestamp":1549843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T00:00:00Z","timestamp":1549843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH110636"],"award-info":[{"award-number":["MH110636"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["MN067234"],"award-info":[{"award-number":["MN067234"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006937","name":"U.S. Department of Health & Human Services | NIH | NICHD | National Center for Medical Rehabilitation Research","doi-asserted-by":"publisher","award":["HD064727"],"award-info":[{"award-number":["HD064727"]}],"id":[{"id":"10.13039\/100006937","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1038\/s41380-019-0368-6","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T13:17:08Z","timestamp":1549891028000},"page":"491-500","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Maternal aripiprazole exposure interacts with 7-dehydrocholesterol reductase mutations and alters embryonic neurodevelopment"],"prefix":"10.1038","volume":"24","author":[{"given":"Thiago C.","family":"Genaro-Mattos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke B.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keri A.","family":"Tallman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ned A.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeljka","family":"Korade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5521-0254","authenticated-orcid":false,"given":"K\u00e1roly","family":"Mirnics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,11]]},"reference":[{"key":"368_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/00041433-200104000-00003","volume":"12","author":"JM Dietschy","year":"2001","unstructured":"Dietschy JM, Turley SD. Cholesterol metabolism in the brain. Curr Opin Lipidol. 2001;12:105\u201312.","journal-title":"Curr Opin Lipidol"},{"key":"368_CR2","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1194\/jlr.R400004-JLR200","volume":"45","author":"JM Dietschy","year":"2004","unstructured":"Dietschy JM, Turley SD. Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res. 2004;45:1375\u201397.","journal-title":"J Lipid Res"},{"key":"368_CR3","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1365-2796.2006.01725.x","volume":"260","author":"I Bjorkhem","year":"2006","unstructured":"Bjorkhem I. Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J Intern Med. 2006;260:493\u2013508.","journal-title":"J Intern Med"},{"key":"368_CR4","doi-asserted-by":"publisher","first-page":"6423","DOI":"10.1021\/cr200021m","volume":"111","author":"WD Nes","year":"2011","unstructured":"Nes WD. Biosynthesis of cholesterol and other sterols. Chem Rev. 2011;111:6423\u201351.","journal-title":"Chem Rev"},{"key":"368_CR5","doi-asserted-by":"publisher","first-page":"R75","DOI":"10.1093\/hmg\/ddg072","volume":"12 Spec No.1","author":"GE Herman","year":"2003","unstructured":"Herman GE. Disorders of cholesterol biosynthesis: prototypic metabolic malformation syndromes. Hum Mol Genet. 2003;12 Spec No.1:R75\u201388.","journal-title":"Hum Mol Genet"},{"key":"368_CR6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1006\/mgme.2001.3226","volume":"74","author":"NA Nwokoro","year":"2001","unstructured":"Nwokoro NA, Wassif CA, Porter FD. Genetic disorders of cholesterol biosynthesis in mice and humans. Mol Genet Metab. 2001;74:105\u201319.","journal-title":"Mol Genet Metab"},{"key":"368_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1006\/mgme.2000.3069","volume":"71","author":"FD Porter","year":"2000","unstructured":"Porter FD. RSH\/Smith-Lemli-Opitz syndrome: a multiple congenital anomaly\/mental retardation syndrome due to an inborn error of cholesterol biosynthesis. Mol Genet Metab. 2000;71:163\u201374.","journal-title":"Mol Genet Metab"},{"key":"368_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1194\/jlr.R009548","volume":"52","author":"FD Porter","year":"2011","unstructured":"Porter FD, Herman GE. Malformation syndromes caused by disorders of cholesterol synthesis. J Lipid Res. 2011;52:6\u201334.","journal-title":"J Lipid Res"},{"key":"368_CR9","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0022-3476(64)80264-X","volume":"64","author":"DW Smith","year":"1964","unstructured":"Smith DW, Lemli L, Opitz JM. A newly recognized syndrome of multiple congenital anomalies. J Pediatr. 1964;64:210\u20137.","journal-title":"J Pediatr"},{"key":"368_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10545-012-9504-z","volume":"36","author":"Z Korade","year":"2012","unstructured":"Korade Z, Xu L, Mirnics K, Porter NA. Lipid biomarkers of oxidative stress in a genetic mouse model of Smith-Lemli-Opitz syndrome. J Inherit Metab Dis. 2012;36:113\u201322.","journal-title":"J Inherit Metab Dis"},{"key":"368_CR11","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1046\/j.1469-1809.2003.00034.x","volume":"67","author":"PE Jira","year":"2003","unstructured":"Jira PE, Waterham HR, Wanders RJ, Smeitink JA, Sengers RC, Wevers RA. Smith-Lemli-Opitz syndrome and the DHCR7 gene. Ann Hum Genet. 2003;67:269\u201380.","journal-title":"Ann Hum Genet"},{"key":"368_CR12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/jmg.37.5.321","volume":"37","author":"RI Kelley","year":"2000","unstructured":"Kelley RI, Hennekam RC. The Smith-Lemli-Opitz syndrome. J Med Genet. 2000;37:321\u201335.","journal-title":"J Med Genet"},{"key":"368_CR13","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1194\/jlr.M041061","volume":"54","author":"K Windsor","year":"2013","unstructured":"Windsor K, Genaro-Mattos TC, Kim HY, Liu W, Tallman KA, Miyamoto S, et al. Probing lipid-protein adduction with alkynyl surrogates: application to Smith-Lemli-Opitz syndrome. J Lipid Res. 2013;54:2842\u201350.","journal-title":"J Lipid Res"},{"key":"368_CR14","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.nbd.2011.12.011","volume":"45","author":"L Xu","year":"2011","unstructured":"Xu L, Mirnics K, Bowman AB, Liu W, Da J, Porter NA, et al. DHCEO accumulation is a critical mediator of pathophysiology in a Smith-Lemli-Opitz syndrome model. Neurobiol Dis. 2011;45:923\u20139.","journal-title":"Neurobiol Dis"},{"key":"368_CR15","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1194\/jlr.M014498","volume":"52","author":"L Xu","year":"2011","unstructured":"Xu L, Korade Z, Rosado DA Jr., Liu W, Lamberson CR, Porter NA. An oxysterol biomarker for 7-dehydrocholesterol oxidation in cell\/mouse models for Smith-Lemli-Opitz syndrome. J Lipid Res. 2011;52:1222\u201333.","journal-title":"J Lipid Res"},{"key":"368_CR16","doi-asserted-by":"publisher","first-page":"13037","DOI":"10.1021\/ja9029076","volume":"131","author":"L Xu","year":"2009","unstructured":"Xu L, Davis TA, Porter NA. Rate constants for peroxidation of polyunsaturated fatty acids and sterols in solution and in liposomes. J Am Chem Soc. 2009;131:13037\u201344.","journal-title":"J Am Chem Soc"},{"key":"368_CR17","doi-asserted-by":"publisher","first-page":"5944","DOI":"10.1021\/cr200084z","volume":"111","author":"H Yin","year":"2011","unstructured":"Yin H, Xu L, Porter NA. Free radical lipid peroxidation: mechanisms and analysis. Chem Rev. 2011;111:5944\u201372.","journal-title":"Chem Rev"},{"key":"368_CR18","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1194\/jlr.M035733","volume":"54","author":"L Xu","year":"2013","unstructured":"Xu L, Korade Z, Rosado DA Jr., Mirnics K, Porter NA. Metabolism of oxysterols derived from nonenzymatic oxidation of 7-dehydrocholesterol in cells. J Lipid Res. 2013;54:1135\u201343.","journal-title":"J Lipid Res"},{"key":"368_CR19","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1194\/jlr.M009365","volume":"51","author":"Z Korade","year":"2010","unstructured":"Korade Z, Xu L, Shelton R, Porter NA. Biological activities of 7-dehydrocholesterol-derived oxysterols: implications for Smith-Lemli-Opitz syndrome. J Lipid Res. 2010;51:3259\u201369.","journal-title":"J Lipid Res"},{"key":"368_CR20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/ajmg.1441","volume":"102","author":"MJ Nowaczyk","year":"2001","unstructured":"Nowaczyk MJ, Nakamura LM, Eng B, Porter FD, Waye JS. Frequency and ethnic distribution of the common DHCR7 mutation in Smith-Lemli-Opitz syndrome. Am J Med Genet. 2001;102:383\u20136.","journal-title":"Am J Med Genet"},{"key":"368_CR21","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/cge.12425","volume":"87","author":"JL Cross","year":"2015","unstructured":"Cross JL, Iben J, Simpson CL, Thurm A, Swedo S, Tierney E, et al. Determination of the allelic frequency in Smith-Lemli-Opitz syndrome by analysis of massively parallel sequencing data sets. Clin Genet. 2015;87:570\u20135.","journal-title":"Clin Genet"},{"key":"368_CR22","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1194\/jlr.M079475","volume":"58","author":"Z Korade","year":"2017","unstructured":"Korade Z, Genaro-Mattos TC, Tallman KA, Liu W, Garbett KA, Koczok K, et al. Vulnerability of DHCR7(+\/\u2212) mutation carriers to aripiprazole and trazodone exposure. J Lipid Res. 2017;58:2139\u201346.","journal-title":"J Lipid Res"},{"key":"368_CR23","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ymgme.2013.04.004","volume":"110","author":"P Hall","year":"2013","unstructured":"Hall P, Michels V, Gavrilov D, Matern D, Oglesbee D, Raymond K, et al. Aripiprazole and trazodone cause elevations of 7-dehydrocholesterol in the absence of Smith-Lemli-Opitz Syndrome. Mol Genet Metab. 2013;110:176\u20138.","journal-title":"Mol Genet Metab"},{"key":"368_CR24","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1021\/acs.chemrestox.6b00054","volume":"29","author":"HY Kim","year":"2016","unstructured":"Kim HY, Korade Z, Tallman KA, Liu W, Weaver CD, Mirnics K, et al. Inhibitors of 7-dehydrocholesterol reductase: screening of a collection of pharmacologically active compounds in Neuro2a cells. Chem Res Toxicol. 2016;29:892\u2013900.","journal-title":"Chem Res Toxicol"},{"key":"368_CR25","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/(SICI)1096-8628(19970131)68:3<322::AID-AJMG14>3.0.CO;2-V","volume":"68","author":"CM Chambers","year":"1997","unstructured":"Chambers CM, McLean MP, Ness GC. Smith-Lemli-Opitz syndrome produced in rats with AY 9944 treated by intravenous injection of lipoprotein cholesterol. Am J Med Genet. 1997;68:322\u20137.","journal-title":"Am J Med Genet"},{"key":"368_CR26","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.steroids.2007.04.005","volume":"72","author":"M Giera","year":"2007","unstructured":"Giera M, Plossl F, Bracher F. Fast and easy in vitro screening assay for cholesterol biosynthesis inhibitors in the post-squalene pathway. Steroids. 2007;72:633\u201342.","journal-title":"Steroids"},{"key":"368_CR27","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1194\/jlr.M026948","volume":"54","author":"A Canfran-Duque","year":"2013","unstructured":"Canfran-Duque A, Casado ME, Pastor O, Sanchez-Wandelmer J, de la Pena G, Lerma M, et al. Atypical antipsychotics alter cholesterol and fatty acid metabolism in vitro. J Lipid Res. 2013;54:310\u201324.","journal-title":"J Lipid Res"},{"key":"368_CR28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.schres.2017.02.001","volume":"187","author":"Z Korade","year":"2017","unstructured":"Korade Z, Liu W, Warren EB, Armstrong K, Porter NA, Konradi C. Effect of psychotropic drug treatment on sterol metabolism. Schizophr Res. 2017;187:74\u201381.","journal-title":"Schizophr Res"},{"key":"368_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.taap.2018.04.029","volume":"349","author":"TC Genaro-Mattos","year":"2018","unstructured":"Genaro-Mattos TC, Tallman KA, Allen LB, Anderson A, Mirnics K, Korade Z, et al. Dichlorophenyl piperazines, including a recently-approved atypical antipsychotic, are potent inhibitors of DHCR7, the last enzyme in cholesterol biosynthesis. Toxicol Appl Pharmacol. 2018;349:21\u201328.","journal-title":"Toxicol Appl Pharmacol"},{"key":"368_CR30","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/JCP.0b013e318222bc65","volume":"31","author":"S Gentile","year":"2011","unstructured":"Gentile S, Tofani S, Bellantuono C. Aripiprazole and pregnancy: a case report and literature review. J Clin Psychopharmacol. 2011;31:531\u20132.","journal-title":"J Clin Psychopharmacol"},{"key":"368_CR31","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1517\/14740338.2014.951325","volume":"13","author":"S Gentile","year":"2014","unstructured":"Gentile S. A safety evaluation of aripiprazole for treating schizophrenia during pregnancy and puerperium. Expert Opin Drug Saf. 2014;13:1733\u201342.","journal-title":"Expert Opin Drug Saf"},{"key":"368_CR32","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/JCP.0b013e3181d27c7d","volume":"30","author":"UC Lutz","year":"2010","unstructured":"Lutz UC, Hiemke C, Wiatr G, Farger G, Arand J, Wildgruber D. Aripiprazole in pregnancy and lactation: a case report. J Clin Psychopharmacol. 2010;30:204\u20135.","journal-title":"J Clin Psychopharmacol"},{"key":"368_CR33","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1345\/aph.1G507","volume":"40","author":"DN Mendhekar","year":"2006","unstructured":"Mendhekar DN, Sharma JB, Srilakshmi P. Use of aripiprazole during late pregnancy in a woman with psychotic illness. Ann Pharmacother. 2006;40:575.","journal-title":"Ann Pharmacother"},{"key":"368_CR34","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00737-008-0022-9","volume":"11","author":"B Mervak","year":"2008","unstructured":"Mervak B, Collins J, Valenstein M. Case report of aripiprazole usage during pregnancy. Arch Womens Ment Health. 2008;11:249\u201350.","journal-title":"Arch Womens Ment Health"},{"key":"368_CR35","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1055\/s-0032-1312591","volume":"45","author":"CG Widschwendter","year":"2012","unstructured":"Widschwendter CG, Hofer A. Aripiprazole use in early pregnancy: a case report. Pharmacopsychiatry. 2012;45:299\u2013300.","journal-title":"Pharmacopsychiatry"},{"key":"368_CR36","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1602\/neurorx.2.4.554","volume":"2","author":"MS Alavijeh","year":"2005","unstructured":"Alavijeh MS, Chishty M, Qaiser MZ, Palmer AM. Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery. NeuroRx. 2005;2:554\u201371.","journal-title":"NeuroRx"},{"key":"368_CR37","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.schres.2009.01.011","volume":"110","author":"JS Wang","year":"2009","unstructured":"Wang JS, Zhu HJ, Donovan JL, Yuan HJ, Markowitz JS, Geesey ME, et al. Aripiprazole brain concentration is altered in P-glycoprotein deficient mice. Schizophr Res. 2009;110:90\u20134.","journal-title":"Schizophr Res"},{"key":"368_CR38","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1172\/JCI200112103","volume":"108","author":"BU Fitzky","year":"2001","unstructured":"Fitzky BU, Moebius FF, Asaoka H, Waage-Baudet H, Xu L, Xu G, et al. 7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz\/RSH syndrome. J Clin Invest. 2001;108:905\u201315.","journal-title":"J Clin Invest"},{"key":"368_CR39","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1093\/hmg\/10.6.555","volume":"10","author":"CA Wassif","year":"2001","unstructured":"Wassif CA, Zhu P, Kratz L, Krakowiak PA, Battaile KP, Weight FF, et al. Biochemical, phenotypic and neurophysiological characterization of a genetic mouse model of RSH\/Smith-Lemli-Opitz syndrome. Hum Mol Genet. 2001;10:555\u201364.","journal-title":"Hum Mol Genet"},{"key":"368_CR40","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1194\/jlr.M600141-JLR200","volume":"47","author":"GS Tint","year":"2006","unstructured":"Tint GS, Yu H, Shang Q, Xu G, Patel SB. The use of the Dhcr7 knockout mouse to accurately determine the origin of fetal sterols. J Lipid Res. 2006;47:1535\u201341.","journal-title":"J Lipid Res"},{"key":"368_CR41","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nm.3407","volume":"19","author":"B Obermeier","year":"2013","unstructured":"Obermeier B, Daneman R, Ransohoff RM. Development, maintenance and disruption of the blood-brain barrier. Nat Med. 2013;19:1584\u201396.","journal-title":"Nat Med"},{"key":"368_CR42","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2147\/nedt.2006.2.4.427","volume":"2","author":"L Citrome","year":"2006","unstructured":"Citrome L. A review of aripiprazole in the treatment of patients with schizophrenia or bipolar I disorder. Neuropsychiatr Dis Treat. 2006;2:427\u201343.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"368_CR43","first-page":"e562","volume":"8","author":"A Muneer","year":"2016","unstructured":"Muneer A. The treatment of adult bipolar disorder with aripiprazole: a systematic review. Cureus. 2016;8:e562.","journal-title":"Cureus"},{"key":"368_CR44","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ijdevneu.2003.09.002","volume":"21","author":"H Waage-Baudet","year":"2003","unstructured":"Waage-Baudet H, Lauder JM, Dehart DB, Kluckman K, Hiller S, Tint GS, et al. Abnormal serotonergic development in a mouse model for the Smith-Lemli-Opitz syndrome: implications for autism. Int J Dev Neurosci. 2003;21:451\u20139.","journal-title":"Int J Dev Neurosci"},{"key":"368_CR45","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.pediatrneurol.2013.03.015","volume":"49","author":"RW Lee","year":"2013","unstructured":"Lee RW, Yoshida S, Jung ES, Mori S, Baker EH, Porter FD. Corpus callosum measurements correlate with developmental delay in Smith-Lemli-Opitz syndrome. Pediatr Neurol. 2013;49:107\u201312.","journal-title":"Pediatr Neurol"},{"key":"368_CR46","first-page":"411","volume":"16","author":"MR Boland","year":"2016","unstructured":"Boland MR, Tatonetti NP. Investigation of 7-dehydrocholesterol reductase pathway to elucidate off-target prenatal effects of pharmaceuticals: a systematic review. Pharm J. 2016;16:411\u201329.","journal-title":"Pharm J"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41380-019-0368-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41380-019-0368-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41380-019-0368-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T20:59:48Z","timestamp":1684616388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-019-0368-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,11]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["368"],"URL":"https:\/\/doi.org\/10.1038\/s41380-019-0368-6","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,11]]},"assertion":[{"value":"25 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}